This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Andrechek, E. R. Articles by Muller, W. J. Search for Related Content PubMed PubMed Citation Articles by Andrechek, E. R. Articles by Muller, W. J.

Gene Expression Profiling of Neu-induced Mammary Tumors from Transgenic Mice Reveals Genetic and Morphological Similarities to ErbB2-expressing Human Breast Cancers¹

Institute for Molecular Biology and Biotechnology, Department of Biology, McMaster University, Hamilton, Canada [E. R. A., M. A. L., A. A. G-G.]; Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 [P. M. S.]; Department of Pathology, School of Medicine, University of California, Davis, California 95616 [R. D. C.]; and Molecular Oncology Labs, McGill University, Royal Victoria Hospital, Montreal, Quebec, H3A 1A1 Canada [W. J. M.]

Numerous studies have shown that the overexpression and amplification of ErbB2/Neu are observed in 20–30% of patients afflicted with breast cancer. Furthermore, it has also been observed that the elevated expression of ErbB2/Neu also correlates with poor prognosis and clinical outcome. Given the prevalence of this disease, we sought to create mouse models that mimic the human condition. In this study, we compared two mouse models expressing activated neu under the control of the endogenous and mouse mammary tumor virus promoters. Although histologically similar, the latency and metastatic potential of these tumors are remarkably different. Gene expression profiling of tumor RNA from the two Neu mouse models revealed distinctive and nonoverlapping patterns of gene expression. Consistent with noninvasive nature of the mammary tumors induced by expression of neu under the endogenous promoter, these tumors expressed a number of markers characteristic of a highly differentiated state. In addition to these differences, these analyses revealed that in contrast to the mouse mammary tumor virus-based Neu model, the endogenous promoter tumors expressed elevated levels of two genes (Grb7 and Cab1) that are closely linked to ErbB2 and often coamplified in noninvasive ductal carcinoma in situ. Furthermore, this analysis has revealed several transcription factors that may be involved in ErbB2-mediated tumorigenesis. Taken together, these results illustrate the similarity of the endogenously regulated Neu tumor model to the human disease.

This article has been cited by other articles:

				N. Dourdin, B. Schade, R. Lesurf, M. Hallett, R. J. Munn, R. D. Cardiff, and W. J. Muller Phosphatase and Tensin Homologue Deleted on Chromosome 10 Deficiency Accelerates Tumor Induction in a Mouse Model of ErbB-2 Mammary Tumorigenesis Cancer Res., April 1, 2008; 68(7): 2122 - 2131. [Abstract] [Full Text] [PDF]

				R. L. Dillon, S. T. Brown, C. Ling, T. Shioda, and W. J. Muller An EGR2/CITED1 Transcription Factor Complex and the 14-3-3{sigma} Tumor Suppressor Are Involved in Regulating ErbB2 Expression in a Transgenic-Mouse Model of Human Breast Cancer Mol. Cell. Biol., December 15, 2007; 27(24): 8648 - 8657. [Abstract] [Full Text] [PDF]

				H. Lu, K. L. Knutson, E. Gad, and M. L. Disis The Tumor Antigen Repertoire Identified in Tumor-Bearing Neu Transgenic Mice Predicts Human Tumor Antigens Cancer Res., October 1, 2006; 66(19): 9754 - 9761. [Abstract] [Full Text] [PDF]

				J. G. Hodgson, T. Malek, S. Bornstein, S. Hariono, D. G. Ginzinger, W. J. Muller, and J. W. Gray Copy Number Aberrations in Mouse Breast Tumors Reveal Loci and Genes Important in Tumorigenic Receptor Tyrosine Kinase Signaling Cancer Res., November 1, 2005; 65(21): 9695 - 9704. [Abstract] [Full Text] [PDF]

				A. Astolfi, L. Landuzzi, G. Nicoletti, C. De Giovanni, S. Croci, A. Palladini, S. Ferrini, M. Iezzi, P. Musiani, F. Cavallo, et al. Gene Expression Analysis of Immune-Mediated Arrest of Tumorigenesis in a Transgenic Mouse Model of HER-2/neu-Positive Basal-Like Mammary Carcinoma Am. J. Pathol., April 1, 2005; 166(4): 1205 - 1216. [Abstract] [Full Text] [PDF]

				E. R. Andrechek, W. R. Hardy, M. A. Laing, and W. J. Muller Germ-line expression of an oncogenic erbB2 allele confers resistance to erbB2-induced mammary tumorigenesis PNAS, April 6, 2004; 101(14): 4984 - 4989. [Abstract] [Full Text] [PDF]

				C. K. Galang, W. J. Muller, G. Foos, R. G. Oshima, and C. A. Hauser Changes in the Expression of Many Ets Family Transcription Factors and of Potential Target Genes in Normal Mammary Tissue and Tumors J. Biol. Chem., March 19, 2004; 279(12): 11281 - 11292. [Abstract] [Full Text] [PDF]